Biggest News Aggregation in the World
📰 Multiple System Atrophy News

Page 32 - Multiple System Atrophy News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Multiple System Atrophy. Real-time updates on events, politics, business and more.

IPO Alert: Inhibikase Therapeutics (IKT)

IPO Alert: Inhibikase Therapeutics (IKT) BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Inhibikase Therapeutics is scheduled to make its debut on the Nasdaq Global Select Market today (December 23), under the ticker symbol IKT. Atlanta, Georgia-based Inhibikase Therapeutics is a clinical stage pharmaceutical company developing therapeutics kinase inhibitors for Parkinsons disease and related disorders. The company has offered to sell 1.8 million shares of its common stock at a price of $10 each. The unde...
Bruxelles Capitale Kostenloser Wertpapierhandel Paulson Investment Company Fordham Financial Management Inc Nasdaq Global Select Market Georgia Based Inhibikase Therapeutics

MODAG Initiates First-in-Patient Phase 1b Trial for Anle138b in Parkinson's Disease

MODAG Initiates First-in-Patient Phase 1b Trial for Anle138b in Parkinsons Disease MODAG, a German biotechnology company focused on the development of disease-modifying small molecule therapeutics for neurodegenerative diseases, today announced the clinical trial initiation of a first-in-patient Phase 1b study for anle138b in patients with mild to moderate Parkinsons Disease (PD). Anle138b is a disease-modifying treatment option for synucleinopathies, such as Multiple System Atrophy (MSA) and P...
United Kingdom Armin Giese Valeria Fisher Kostenloser Wertpapierhandel Johannes Levin Torsten Matthias

Alterity, UniQuest team up to reverse bacterial resistance to antibiotics

Alterity, UniQuest team up to reverse bacterial resistance to antibiotics Alterity, UniQuest team up to reverse bacterial resistance to antibiotics 22 December 2020 | News Alterity has secured the worldwide exclusive right to patented technology to develop and commercialize therapies that re-sensitize bacteria to antibiotics Photo Credit: Freepik Alterity Therapeutics has announced it has been granted a licence by UniQuest, the commercialisation company of The University of Queensl...
Geoffrey Kempler Mark Walker University Of Queensland Alterity Therapeutics Multiple System Atrophy ஜெஃப்ரி கேம்பிளேர்

Alterity and UniQuest partner to reverse bacterial resistance to antibiotics

Alterity and UniQuest partner to reverse bacterial resistance to antibiotics New commercial opportunity for PBT2 News provided by Share this article Share this article MELBOURNE, Australia, Dec. 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH,NASDAQ: ATHE) ("Alterity" or "the Company") has today announced it has been granted a licence by UniQuest, the commercialisation company of The University of Queensland (UQ), to novel zinc ionophore technology to combat antimicrobial resistance in...
Geoffrey Kempler Mark Walker University Of Queensland World Health Organisation Science Translational Dean Moss

William T. 'Bill' O'Connor Jr., 81, hardworking family man who enjoyed genealogy

William T. ‘Bill’ O’Connor Jr. WILLIAMSBURG — William T. ‘Bill’ O’Connor Jr., 81, passed away peacefully at home with family by his side Wednesday, Dec. 9, 2020. Bill was born Sept. 10, 1939, to William Thomas O’Connor Sr. and Pauline Kelly O’Connor. He was raised in West Point and Deltaville. In 1957, he graduated from West Point High School. He went on to serve in the U.S. Air Force from 1957 to 1961. Much of his time, he was stationed in Alaska. In 1967, Bill began working...
United States San Antonio West Point William Thomas Oconnor Pauline Kelly Oconnor Insun Monica Seo

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science